ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Denosumab-Teva onco 120 mg / 1.7 ml, Injektionslösung - 
70132001 Teva Pharma AG
Denosumab-Teva onco 120 mg / 1.7 ml, Injektionslösung10.12.2025
Generic10.12.2025
Denosumab (M05BX04) 
WHO-DDD09.12.2030
70000. 
07.16.10. 
A  
Yes 
IP 
 Yes
    
10 % 
  
7680701320015Biotechnologika
  
Composition
denosumabum 120 mg, natrii acetas trihydricus corresp. natrium 0.49 mg, acidum aceticum glaciale, sorbitolum 79.9 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml.
Packungsbestandteile
 
Source
Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home